Viewing Study NCT06507150



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06507150
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-04

Brief Title: AI-assisted Migraine Education Efficacy Safety and Patients Acceptance
Sponsor: None
Organization: None

Study Overview

Official Title: AI-assisted Migraine Education Efficacy Safety and Patients Acceptance
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Migraine affects 1 in 7 people globally significantly impacting quality of life and economic productivity Despite its prevalence limited awareness leads to misdiagnosis inadequate treatment and stigmatization AI can enhance migraine management through improved diagnosis prediction and personalized education The primary objective of this study is to determine if adding AI-assisted migraine education to standard education improves patients understanding of their condition more effectively
Detailed Description: Migraine affecting approximately 1 in 7 individuals globally significantly impacts quality of life and economic productivity due to its associated healthcare and social burdens Despite its prevalence awareness and understanding of migraine remain limited contributing to misdiagnosis inadequate treatment and the perpetuation of stigmatization

Artificial Intelligence AI may advance migraine management by improving diagnosis prediction and educational outreach AI applications are currently being employed in diagnosing migraines more accurately by analyzing comprehensive patient data thus differentiating migraine from other types of headaches Additionally AI algorithms predict migraine episodes enabling preemptive measures They also streamline medication management through reminders and monitor patient adherence which is crucial for preventing medication overuse and optimizing treatment outcomes

Moreover AI can bridge the educational gap in migraine understanding By using adaptive learning technologies AI platforms can deliver personalized educational content tailored to an individuals knowledge level and learning pace enhancing understanding and engagement This approach not only facilitates better management of the condition but also promotes a broader societal awareness essential for destigmatizing migraine

The primary objective of this study is to ascertain if the addition of AI-assisted migraine education to standard migraine education yields a superior improvement in the patients understanding of their condition

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None